DAVID M MOTT Insider Trading Transactions
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in TESARO, Inc. ($TSRO) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Dermira, Inc. ($DERM) and Director in Epizyme, Inc. ($EPZM) and 10% Owner in Loxo Oncology, Inc. ($LOXO).
Latest Insider Trading Transactions of DAVID M MOTT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HIVE, BOX, CRCM, CLVS, CVT, DERM, EPZM, ILIU, LOXO, MM, OMTH, ROKA, TSRO, TCON, WDAY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2015 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 5,373,396 | 0 | 0 | |
Feb 05 2015 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,888,474 | 1.4 M to 1.9 M (+36.01 %) |
Feb 05 2015 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,388,474 | 0 | 1,388,474 | 0 to 1.4 M |
Jan 29 2015 | BOX | BOX INC | MOTT DAVID M | 10% Owner | Option Exercise | J | 0.00 | 2,091,457 | 0 | 2,091,457 | |
Jan 29 2015 | BOX | BOX INC | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 274,916 | 0 | 0 | |
Jan 29 2015 | BOX | BOX INC | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,653,761 | 0 | 0 | |
Jan 29 2015 | BOX | BOX INC | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 2,091,457 | 0 | 0 | 2.1 M to 0 (-100.00 %) |
Jan 29 2015 | BOX | BOX INC | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,928,677 | 0 | 2,091,457 | 162.8 K to 2.1 M (+1,184.84 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Oct 08 2014 | DERM | Dermira, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 382,840 | 0 | 0 | |
Oct 08 2014 | DERM | Dermira, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 655,321 | 0 | 0 | |
Oct 08 2014 | DERM | Dermira, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 2,378,408 | 0 | 0 | |
Oct 08 2014 | DERM | Dermira, Inc. | MOTT DAVID M | 10% Owner | Buy | P | 16.00 | 69,112 | 1,105,792 | 3,502,922 | 3.4 M to 3.5 M (+2.01 %) |
Oct 08 2014 | DERM | Dermira, Inc. | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 3,416,569 | 0 | 3,433,810 | 17.2 K to 3.4 M (+19,816.54 %) |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 5,987,892 | 0 | 0 | |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 8,555,784 | 0 | 0 | |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 4,030,224 | 0 | 0 | |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 12,360,000 | 0 | 0 | |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Buy | P | 12.00 | 383,333 | 4,599,996 | 3,216,810 | 2.8 M to 3.2 M (+13.53 %) |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 542,381 | 0 | 2,833,477 | 2.3 M to 2.8 M (+23.67 %) |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 801,741 | 0 | 2,291,096 | 1.5 M to 2.3 M (+53.83 %) |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 365,056 | 0 | 1,489,355 | 1.1 M to 1.5 M (+32.47 %) |
Jul 22 2014 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,119,565 | 0 | 1,124,299 | 4.7 K to 1.1 M (+23,649.45 %) |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,558,651 | 0 | 0 | |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | MOTT DAVID M | 10% Owner | Buy | P | 13.00 | 230,769 | 2,999,997 | 1,789,420 | 1.6 M to 1.8 M (+14.81 %) |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,558,651 | 0 | 1,558,651 | 0 to 1.6 M |
Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
Jul 28 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
Aug 19 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Sell | S | 26.52 | 505 | 13,393 | 0 | 505 to 0 (-100.00 %) |
Aug 18 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 505 | 0 | 505 | 0 to 505 |
Aug 18 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Aug 18 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Aug 18 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 4,994,106 | 6 M to 5 M (-16.68 %) |
Jun 04 2014 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | A | 26.36 | 10,000 | 263,600 | 10,000 | |
Jun 04 2014 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Grant | A | 0.00 | 3,186 | 0 | 8,677 | 5.5 K to 8.7 K (+58.02 %) |
Apr 03 2014 | HIVE | AEROHIVE NETWORKS, ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,065,143 | 0 | 0 | |
Apr 03 2014 | HIVE | AEROHIVE NETWORKS, ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 3,588,446 | 0 | 0 | |
Apr 03 2014 | HIVE | AEROHIVE NETWORKS, ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 4,653,589 | 0 | 4,673,589 | 20 K to 4.7 M (+23,267.95 %) |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 612,089 | 0 | 0 | |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 401,837 | 0 | 0 | |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 2,242,087 | 0 | 0 | |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 612,089 | 0 | 3,256,013 | 2.6 M to 3.3 M (+23.15 %) |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 401,837 | 0 | 2,643,924 | 2.2 M to 2.6 M (+17.92 %) |
Jan 29 2014 | CRCM | Care.com Inc | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 2,242,087 | 0 | 2,242,087 | 0 to 2.2 M |
Jan 23 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Sell | S | 35.50 | 169,887 | 6,030,989 | 5,994,106 | 6.2 M to 6 M (-2.76 %) |
Jan 21 2014 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Sell | S | 35.50 | 1,132,589 | 40,206,910 | 6,163,993 | 7.3 M to 6.2 M (-15.52 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
Jul 18 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Sell | D | 0.00 | 5,833,213 | 0 | 0 | 5.8 M to 0 (-100.00 %) |
Aug 14 2013 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 7,296,582 | 0 | 0 | |
Aug 14 2013 | CVT | CVENT INC | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 7,296,582 | 0 | 7,296,582 | 0 to 7.3 M |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 2,321,212 | 0 | 4,642,425 | |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 1,171 | 0 | 1,171 | 0 to 1.2 K |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 23,212 | 0 | 0 | 23.2 K to 0 (-100.00 %) |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 23,212 | 0 | 23,212 | 0 to 23.2 K |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 2,321,212 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Apr 11 2013 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 2,321,212 | 0 | 2,321,212 | 0 to 2.3 M |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | A | 46.22 | 10,000 | 462,200 | 10,000 | |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 829 | 0 | 829 | 0 to 829 |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Grant | A | 0.00 | 1,330 | 0 | 5,491 | 4.2 K to 5.5 K (+31.96 %) |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 16,450 | 0 | 0 | 16.5 K to 0 (-100.00 %) |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 16,450 | 0 | 16,450 | 0 to 16.5 K |
Jun 05 2013 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 1,645,000 | 0 | 9,854,255 | 11.5 M to 9.9 M (-14.31 %) |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 6,165,747 | 0 | 0 | |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Option Exercise | C | 8.00 | 633,219 | 5,065,752 | 0 | |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Option Exercise | C | 0.01 | 156,250 | 1,563 | 0 | |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Buy | P | 8.00 | 625,000 | 5,000,000 | 5,833,213 | 5.2 M to 5.8 M (+12.00 %) |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Buy | C | 0.00 | 4,418,940 | 0 | 5,208,213 | 789.3 K to 5.2 M (+559.87 %) |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Buy | C | 8.00 | 633,219 | 5,065,752 | 789,273 | 156.1 K to 789.3 K (+405.77 %) |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Sell | S | 8.00 | 196 | 1,568 | 156,054 | 156.3 K to 156.1 K (-0.13 %) |
Apr 17 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Buy | C | 0.01 | 156,250 | 1,563 | 156,250 | 0 to 156.3 K |
Apr 11 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Option Exercise | A | 8.00 | 633,219 | 5,065,752 | 633,219 | |
Apr 11 2013 | OMTH | Omthera Pharmaceut ... | MOTT DAVID M | Director | Option Exercise | A | 0.01 | 156,250 | 1,563 | 156,250 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 575 | 0 | 575 | 0 to 575 |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 11,399 | 0 | 0 | 11.4 K to 0 (-100.00 %) |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Buy | J | 0.00 | 11,399 | 0 | 11,399 | 0 to 11.4 K |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Sell | J | 0.00 | 1,139,890 | 0 | 2,279,781 | 3.4 M to 2.3 M (-33.33 %) |
Oct 18 2012 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 6,963,637 | 0 | 6,963,637 | |
Oct 18 2012 | WDAY | Workday, Inc. | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 6,963,637 | 0 | 0 | |
Oct 17 2012 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Grant | A | 0.00 | 4,161 | 0 | 4,161 | 0 to 4.2 K |
Oct 30 2012 | MM | Millennial Media I ... | MOTT DAVID M | 10% Owner | Sell | S | 13.44 | 1,597,787 | 21,478,252 | 8,196,614 | 9.8 M to 8.2 M (-16.31 %) |
Jul 03 2012 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 5,253,859 | 0 | 0 | |
Jul 03 2012 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 5,134,285 | 0 | 0 | |
Jul 03 2012 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | P | 13.50 | 1,111,111 | 14,999,999 | 11,499,255 | 10.4 M to 11.5 M (+10.70 %) |
Jul 03 2012 | TSRO | TESARO, Inc. | MOTT DAVID M | Director | Buy | C | 0.00 | 10,388,144 | 0 | 10,388,144 | 0 to 10.4 M |
Apr 04 2012 | MM | Millennial Media I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,758,302 | 0 | 0 | |
Apr 04 2012 | MM | Millennial Media I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 8,036,099 | 0 | 0 | |
Apr 04 2012 | MM | Millennial Media I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 9,794,401 | 0 | 9,794,401 | 0 to 9.8 M |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 377,124 | 0 | 0 | |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 2,612,330 | 0 | 0 | |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,206,897 | 0 | 0 | |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,186,897 | 0 | 0 | |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Buy | P | 13.00 | 1,316,299 | 17,111,887 | 3,419,671 | 2.1 M to 3.4 M (+62.58 %) |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 377,124 | 0 | 2,103,372 | 1.7 M to 2.1 M (+21.85 %) |
Nov 22 2011 | CLVS | Clovis Oncology, I ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,726,248 | 0 | 1,726,248 | 0 to 1.7 M |
Page: 1